Vinh Luong
Examiner (ID: 9155, Phone: (571)272-7109 , Office: P/3656 )
Most Active Art Unit | 3656 |
Art Unit(s) | 3502, 3656, 3681, 3508, 2899, 3682, 3622, 3736 |
Total Applications | 3233 |
Issued Applications | 2366 |
Pending Applications | 116 |
Abandoned Applications | 750 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5727457
[patent_doc_number] => 20060058217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Compositions and methods for treatment of ovarian cancer'
[patent_app_type] => utility
[patent_app_number] => 10/541474
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5749
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20060058217.pdf
[firstpage_image] =>[orig_patent_app_number] => 10541474
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/541474 | Compositions and methods for treatment of ovarian cancer | Jan 19, 2004 | Abandoned |
Array
(
[id] => 5799424
[patent_doc_number] => 20060034911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'New oral immediated release dosage form'
[patent_app_type] => utility
[patent_app_number] => 10/537858
[patent_app_country] => US
[patent_app_date] => 2003-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4082
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034911.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537858
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537858 | New oral immediated release dosage form | Dec 7, 2003 | Abandoned |
Array
(
[id] => 5716177
[patent_doc_number] => 20060079540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Pde4 and pde3/4 inhibitors for use in the treatment of cachexia'
[patent_app_type] => utility
[patent_app_number] => 10/535815
[patent_app_country] => US
[patent_app_date] => 2003-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5580
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079540.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535815
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535815 | Pde4 and pde3/4 inhibitors for use in the treatment of cachexia | Nov 25, 2003 | Abandoned |
Array
(
[id] => 5649853
[patent_doc_number] => 20060135588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Preventive and/or therapeutic drugs for inflammatory intestinal diseases'
[patent_app_type] => utility
[patent_app_number] => 10/526943
[patent_app_country] => US
[patent_app_date] => 2003-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5765
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135588.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526943
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526943 | Preventive and/or therapeutic drugs for inflammatory intestinal diseases | Sep 8, 2003 | Abandoned |
Array
(
[id] => 5875441
[patent_doc_number] => 20060167045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin II type I receptor antagonist'
[patent_app_type] => utility
[patent_app_number] => 10/524865
[patent_app_country] => US
[patent_app_date] => 2003-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9003
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20060167045.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524865 | Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin II type I receptor antagonist | Aug 14, 2003 | Abandoned |
Array
(
[id] => 6926631
[patent_doc_number] => 20050239888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Pharmaceutical compositions containing keto-acids for endoperitoneal administration'
[patent_app_type] => utility
[patent_app_number] => 10/522154
[patent_app_country] => US
[patent_app_date] => 2003-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1733
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239888.pdf
[firstpage_image] =>[orig_patent_app_number] => 10522154
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/522154 | Pharmaceutical compositions containing keto-acids for endoperitoneal administration | Jul 24, 2003 | Abandoned |
Array
(
[id] => 5733614
[patent_doc_number] => 20060258731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Antitumor compound and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/522081
[patent_app_country] => US
[patent_app_date] => 2003-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4487
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258731.pdf
[firstpage_image] =>[orig_patent_app_number] => 10522081
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/522081 | Antitumor compound and therapeutic uses thereof | Jul 21, 2003 | Abandoned |
Array
(
[id] => 5794158
[patent_doc_number] => 20060014839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Combination of angiotensin II receptor blocker and beta-blocker for secondary prevention of myocardial infarction'
[patent_app_type] => utility
[patent_app_number] => 10/514681
[patent_app_country] => US
[patent_app_date] => 2003-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18098
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014839.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514681
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514681 | Combination of angiotensin II receptor blocker and beta-blocker for secondary prevention of myocardial infarction | May 15, 2003 | Abandoned |
Array
(
[id] => 7051362
[patent_doc_number] => 20050187249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Lypohilization product'
[patent_app_type] => utility
[patent_app_number] => 10/513339
[patent_app_country] => US
[patent_app_date] => 2003-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5003
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187249.pdf
[firstpage_image] =>[orig_patent_app_number] => 10513339
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/513339 | Lypohilization product | May 12, 2003 | Abandoned |
Array
(
[id] => 5721304
[patent_doc_number] => 20060074080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Combination product comprising melagatran and an anti-arrhythmic oxabispidenes'
[patent_app_type] => utility
[patent_app_number] => 10/513187
[patent_app_country] => US
[patent_app_date] => 2003-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9676
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074080.pdf
[firstpage_image] =>[orig_patent_app_number] => 10513187
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/513187 | Combination product comprising melagatran and an anti-arrhythmic oxabispidenes | May 4, 2003 | Abandoned |
Array
(
[id] => 7145641
[patent_doc_number] => 20050119259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes'
[patent_app_type] => utility
[patent_app_number] => 10/513190
[patent_app_country] => US
[patent_app_date] => 2003-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12861
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20050119259.pdf
[firstpage_image] =>[orig_patent_app_number] => 10513190
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/513190 | Combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes | May 4, 2003 | Abandoned |
Array
(
[id] => 7040726
[patent_doc_number] => 20050159481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Medicinal composition for improving angiotension-regulating function of blood vessel endothelium'
[patent_app_type] => utility
[patent_app_number] => 10/511587
[patent_app_country] => US
[patent_app_date] => 2003-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3385
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20050159481.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511587
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511587 | Medicinal composition for improving angiotension-regulating function of blood vessel endothelium | Apr 17, 2003 | Abandoned |
Array
(
[id] => 7105582
[patent_doc_number] => 20050107470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia'
[patent_app_type] => utility
[patent_app_number] => 10/510450
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2537
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107470.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510450
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510450 | Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia | Apr 7, 2003 | Abandoned |
Array
(
[id] => 7070055
[patent_doc_number] => 20050245440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2'
[patent_app_type] => utility
[patent_app_number] => 10/510214
[patent_app_country] => US
[patent_app_date] => 2003-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9863
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245440.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510214
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510214 | Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2 | Apr 6, 2003 | Abandoned |
Array
(
[id] => 5189071
[patent_doc_number] => 20070167380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Taste masked compositions of erythromycin a and derivatives thereof'
[patent_app_type] => utility
[patent_app_number] => 10/509824
[patent_app_country] => US
[patent_app_date] => 2003-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2819
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167380.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509824
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509824 | Taste masked compositions of erythromycin a and derivatives thereof | Apr 2, 2003 | Abandoned |
Array
(
[id] => 5769497
[patent_doc_number] => 20060020046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies'
[patent_app_type] => utility
[patent_app_number] => 10/504829
[patent_app_country] => US
[patent_app_date] => 2003-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3595
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20060020046.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504829
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504829 | Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies | Feb 5, 2003 | Abandoned |
Array
(
[id] => 7180533
[patent_doc_number] => 20050124557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Use of benzothiazepines having activity as inhibitors of ileal bile acid transport for reducing cholesterololemia'
[patent_app_type] => utility
[patent_app_number] => 10/502355
[patent_app_country] => US
[patent_app_date] => 2003-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16687
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20050124557.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502355
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502355 | Use of benzothiazepines having activity as inhibitors of ileal bile acid transport for reducing cholesterololemia | Jan 22, 2003 | Abandoned |